Skip global navigation and read the article

Skip global navigation and go to local navigation

Skip global navigation and go to footer navigation



Home  > Press Release  > A Novel, Tumor-Induced Osteoclastogenesis Pathway In sensitive to Denosumab but Interfered by Cannabidiol

A Novel, Tumor-Induced Osteoclastogenesis Pathway In sensitive to Denosumab but Interfered by Cannabidiol

Abstract

Bone metabolism is strictly regulated, and impaired regulation caused by hormonal imbalances induces systemic bone loss. Local bone loss caused by tumor invasion into bone is suggested to be induced by the generation of cytokines, which affect bone metabolism, by tumor cells. The major cause of systemic and local bone losses is excess bone resorption by osteoclasts, which differentiate from macrophages by receptor activator of nuclear factor kappa-B ligand (RANKL) or tumor necrosis factor-alpha (TNF-α). We previously found a novel pathway for tumor-induced osteoclastogenesis targeting osteoclast precursor cells (OPCs). Tumor-induced osteoclastogenesis was resistant to RANKL and TNF-α inhibitors. In the present study, we confirmed that exosomes derived from oral squamous cell carcinoma (OSCC) cells induced osteoclasts from OPCs. We also showed that the depletion of exosomes from culture supernatants of OSCC cells partially interfered with osteoclastogenesis, and cannabidiol, an innoxious cannabinoid without psychotropic effects, almost completely suppressed tumor-induced osteoclastogenesis. Osteoclastogenesis and its interference by cannabidiol were independent of the expression of nuclear factor of T cell c1 (NFATc1). These results show that osteoclastogenesis induced by OSCC cells targeting OPCs is a novel osteoclastogenic pathway independent of NFATc1 expression that is partially caused by tumor-derived exosomes and suppressed by cannabidiol.

Journal Article

JOURNAL:
International Journal of Molecular Sciences

TITLE:
A Novel, Tumor-Induced Osteoclastogenesis Pathway In sensitive to Denosumab but Interfered by Cannabidiol

DOI:
https://doi.org/10.3390/ijms20246211

Correspondence to

IKEDA Tohru , DDS, Ph.D., Professor
Oral Pathology,
Graduate School of Medical and Dental Sciences,
Tokyo Medical and Dental University(TMDU)
E-mail:tohrupth.mpa(at)tmd.ac.jp


*Please change (at) in e-mail addresses to @ on sending your e-mail to contact personnels.